TDOCTDOC
US • —
$8.48
P/E
—
PEG
—
FCF Yield
—
Rev Growth YoY
-1.5% YoY
Gross Margin
69.3%
Health Score
4/10
D/E Ratio
0.72
Confidence
LOW
Business Snapshot
Teladoc Health provides virtual healthcare services, including telehealth consultations and mental health support, through its BetterHelp and Livongo platforms. The company operates in the competitive telehealth and digital health market, where it maintains a leading position with a significant patient base but faces increasing competition from other virtual care providers. Financial scale details are limited, as certain core fundamentals are unavailable. The company differentiates itself through a comprehensive integrated care model that combines mental health, chronic condition management, and general medical consultations under one platform. However, it has yet to achieve sustained profitability, reflected in a net loss over the trailing twelve months.
Financial Health
Gross margin stands at a robust 69.3%, while the net margin (TTM) is deeply negative at -6.8%, indicating significant operating costs relative to revenue. The balance sheet shows a moderate Debt/Equity ratio of 0.72x, which is manageable, and a Current Ratio of 2.77x, providing ample short-term liquidity to cover liabilities...
Risk Assessment
- EARNINGS QUALITY — Only 2 of the last 4 recent quarters beat earnings estimates, indicating mixed earnings reliability and inconsistent management guidance.
- REVENUE DECELERATION — Revenue declined by 1.5% year-over-year, representing a reversal from growth and signalling a contracting top line.
- PROFITABILITY — Net margin (TTM) of -6.8% and Return on Equity of -12.4% confirm the company is operating at a persistent loss and destroying shareholder equity.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- INSIDER ACTIVITY — 6 insider sells versus 0 buys over the last 90 days, a strongly bearish signal from those with the deepest knowledge of the company.
- DATA COMPLETENESS — 2 core fundamental metrics (P/E, revenue, FCF) are unavailable, creating a 'fundamental data vacuum' that significantly increases investment risk....
Gross margin stands at a robust 69.3%, while the net margin (TTM) is deeply negative at -6.8%, indicating significant operating costs relative to revenue. The balance sheet shows a moderate Debt/Equity ratio of 0.72x, which is manageable, and a Current Ratio of 2.77x, providing ample short-term liquidity to cover liabilities. Return on equity is deeply negative at -12.4%, signalling the business has been failing to generate profit from shareholder equity. Free cash flow figures are unavailable, preventing a clear assessment of cash generation or burn. Overall, while the company has healthy liquidity and a manageable debt load, persistent net losses and a negative return on equity suggest it is not yet self-sustaining and may require external funding or eventual dilution to support operations.
- EARNINGS QUALITY — Only 2 of the last 4 recent quarters beat earnings estimates, indicating mixed earnings reliability and inconsistent management guidance. - REVENUE DECELERATION — Revenue declined by 1.5% year-over-year, representing a reversal from growth and signalling a contracting top line. - PROFITABILITY — Net margin (TTM) of -6.8% and Return on Equity of -12.4% confirm the company is operating at a persistent loss and destroying shareholder equity. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - INSIDER ACTIVITY — 6 insider sells versus 0 buys over the last 90 days, a strongly bearish signal from those with the deepest knowledge of the company. - DATA COMPLETENESS — 2 core fundamental metrics (P/E, revenue, FCF) are unavailable, creating a 'fundamental data vacuum' that significantly increases investment risk.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives